T he endothelium protects the organism from a number of diseases, including vascular disease and insulin resistance. 1, 2 However, diabetes mellitus and cardiovascular risk factors cause changes in the endothelium, leading to endothelial dysfunction. Elevated levels of fatty acids are generally believed to result in endothelial dysfunction. 3 Palmitic acid (16:0) and stearic acid (18:0) are 2 common saturated fatty acids that cause endothelial dysfunction in vitro, including proinflammatory signaling and apoptosis. [4] [5] [6] Increased activation of the ceramide pathway and toll-like receptor 4 (TLR4) have been implicated in the proinflammatory changes elicited by palmitate. 5, [7] [8] [9] [10] However, the mechanism by which TLR4 is modulated by saturated fatty acids remains controversial. 11 Saturated fatty acids also induce apoptosis by a pathway that appears to require endoplasmic reticulum (ER) membrane saturation and subsequent ER stress, 12 as well as activation of nuclear factor-κB signaling. 13 ER stress induces apoptosis through activation of the protein kinase c-Jun N-terminal kinase (JNK) in many cells.
14 These mechanisms require conversion of the free saturated fatty acids to their acyl-CoA derivatives.
Long-chain acyl-CoA synthetase (ACSL) isoforms ligate long-chain fatty acids to the CoA moiety. Conversion of free fatty acids into their acyl-CoA derivatives is required for channeling of fatty acids into cellular lipid pools and β-oxidation, and most of the biological actions of fatty acids in cells. 15 Of the 5 ACSL isoforms expressed in mammals, ACSL1, ACSL3, ACSL4, and ACSL5 are expressed in endothelial cells (ECs). 16 Specific functions of these ACSL isoforms in ECs are unknown.
Forced overexpression of ACSL1 in the heart causes cardiac lipotoxicity and increased apoptosis, 17 whereas ACSL1 deficiency in myeloid cells protects against the inflammatory effects of diabetes mellitus in monocytes and macrophages, as well as diabetes-accelerated atherosclerosis. 18 We therefore hypothesized that ACSL1-dependent acyl-CoA synthesis mediates the detrimental effects of saturated fatty acids in ECs in vitro and in vivo.
Our findings show that forced overexpression of ACSL1 in ECs indeed exacerbates saturated fatty acid-induced apoptosis and ER stress. However, ACSL1-deficiency does not protect ECs against the proinflammatory and proapoptotic effects of saturated fatty acids in vitro, nor does it protect against increased adipose tissue macrophage accumulation or aortic expression of vascular cell adhesion molecule 1 (Vcam1) in a saturated fat-fed mouse model of insulin resistance. These findings suggest that when overexpressed, ACSL1 is sufficient to exacerbate the effects of saturated fatty acids on ER stress and apoptosis, but that normally, ACSL1 does not contribute in major ways to these effects of saturated fatty acids, or to inflammatory changes associated with high-fat diet feeding.
Materials and Methods

Generation of Conditional ACSL1 Endothelial and Hematopoietic-Deficient Mice
Acsl1
flox/flox mice were generated, as described previously, 19 and backcrossed 10 generations into the C57BL/6 background. These mice were then crossed with Tie2-Cre mice (The Jackson Laboratory, Bar Harbor, ME) on a C57BL/6 background to obtain mice with endothelial and hematopoietic ACSL1 deficiency. Female breeders were Crenegative to avoid germ-line transmission. The resulting Acsl1 
Insulin-Resistant Obese Mouse Model
Male ACSL1
E/H-/-mice and WT littermate controls (10-12 weeks of age) were fed chow diet or a diabetogenic diet with added cholesterol (DDC) rich in saturated fatty acids for 20 weeks, as previously described. 20, 21 Glucose tolerance tests were performed at week 18, as previously described.
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Isolation and Culture of Endothelial Cells
Mouse microvascular endothelial cells (MMECs) were isolated by a fluorescence-activated cell-sorting method from lungs or hearts, 22 or by a magnetic bead positive-selection method from hearts using an intracellular adhesion molecule 2 antibody, as previously described. 23 Most of the experiments were performed on heart MMECs isolated by the magnetic bead separation method between passage 3 and 6. Bovine aortic endothelial cells (BAECs) were purchased from Cambrex Bioscience (Walkersville, MD).
Additional methods are described in the online-only Data Supplemental Materials.
Results
Palmitate and Stearate Promote Inflammatory Changes and Apoptosis in Mouse Microvascular Endothelial Cells
MMECs exposed to palmitate (16:0) or stearate (18:0) bound to BSA at indicated molar ratios for 24 hours exhibited dosedependent increases in secretion of the chemokines CCL2 (chemokine [C-C motif] ligand 2) and CXCL1 (chemokine [C-X-C motif] ligand 1), as well as increased shedding of soluble vascular cell adhesion molecule 1 (sVCAM-1) and soluble intracellular adhesion molecule 1 (sICAM-1), as shown in Figure 1A through 1D. Significant effects of 16:0 were observed at 1:2 and 1:3 BSA:fatty acid molar ratios, corresponding to 156 μmol/L and 234 μmol/L 16:0, respectively, whereas 18:0 was more potent and induced significant changes at 1:0.5 to 1:1 BSA:fatty acid molar ratios, corresponding to 39 μmol/L and 78 μmol/L, respectively. These concentrations of 18:0 are in the physiological range for human plasma. 24 Stearate and palmitate also induced increased caspase 3 activity in these MMECs ( Figure 1E ) and apoptosis ( Figure 1F ). Again, stearate was more potent than palmitate ( Figure 1F ). Thus, saturated fatty acids, and particularly stearate, induce an inflammatory response and apoptosis in MMECs, consistent with studies on ECs from other vascular beds and species. 13, 25, 26 Forced Overexpression of ACSL1 Results in Increased Palmitoyl-CoA and StearoylCoA levels, and Exacerbated Apoptosis, ER Stress, and JNK Activation in PalmitateStimulated Bovine Aortic Endothelial Cells
The proinflammatory and proapoptotic effects of saturated fatty acids are likely to be mediated by the acyl-CoA derivatives of these fatty acids, as discussed above. To investigate the effect of ACSL1 on saturated fatty acid-induced changes in ECs, we next stably overexpressed ACSL1 by using a retroviral vector in BAECs. BAECs were used for these experiments because of their greater proliferative capacity compared with MMECs. Both 16:0 and 18:0 increased chemokine (Ccl2) expression and cell death in these cells, like in MMECs, whereas oleate (18:1) prevented these effects ( Figure IA and IB in the online-only Data Supplement). The proinflammatory and proapoptotic effects of 16:0 were also prevented by triacsin C, an acylCoA synthetase inhibitor that inhibits most ACSL isoforms, consistent with previous studies 13, 26 ( Figure IC -IE in the onlineonly Data Supplement). BAECs infected with the ACSL1 retroviral vector exhibited clearly detectable myelocytomatosis oncogene-tagged ACSL1 protein compared with the empty vector (pBM)-infected controls (Figure 2A ). Consistent with these observations, cell extracts from BAECs overexpressing ACSL1 exhibited a significant increase in palmitoyl-CoA synthesis ( Figure 2B ). Whereas there were no significant differences in acyl-CoA levels between ACSL1-overexpressing cells and controls under basal low-serum conditions, both palmitoyl-CoA and stearoyl-CoA levels increased in palmitatestimulated cells overexpressing ACSL1 ( Figure 2C ). Forced ACSL1 overexpression exacerbated palmitate-induced BAEC cell death and caspase 3 activity ( Figure 2D and 2E). Saturated fatty acids can promote JNK activation, thereby inducing apoptosis and proinflammatory changes in different cell types. 27 To investigate whether ACSL1 overexpression exacerbates the effects of 16:0 on JNK activation, BAECs were stimulated with 16:0 for 4 hours. Cells stimulated with 16:0 demonstrated an increased JNK phosphorylation, and ACSL1 overexpression further increased 16:0-induced JNK phosphorylation ( Figure 2F and 2G).
ER stress is often linked to JNK activation. 28, 29 Therefore, Hspa5 (Grp78) mRNA, an ER stress marker, was used to evaluate ER stress in control and ACSL1-overexpressing BAECs. Consistent with the JNK activation, Hspa5 mRNA levels were increased by palmitate-stimulation, and overexpression of ACSL1 resulted in a further elevation of Hspa5 mRNA levels ( Figure 2H ). Increased ER stress has been shown to be associated with an increased presence of saturated fatty acids in the membrane, and consistently, palmitate-stimulated BAECs exhibited a marked increase in membrane palmitate levels, which was exacerbated by ACSL1 overexpression ( Figure 2I ). Thus, ACSL1 overexpression results in membrane fatty acid saturation after palmitate-stimulation, and accompanied ER stress, JNK activation, and increased apoptosis.
To investigate whether the increased JNK activation contributes to apoptosis in palmitate-stimulated BAECs, we used the cell-permeable JNK Inhibitor I (EMD Millipore). As shown in Figure 2J , the JNK inhibitor partly, but significantly, protected palmitate-stimulated BAECs as well as ACSL1-overexpressing BAECs from apoptosis, as measured by reduced DNA fragmentation (TUNEL). Similar results were obtained using an unrelated JNK inhibitor (SP600125, Biomol; data not shown), suggesting that activation of the JNK pathway is, in part, responsible for the increased apoptosis in palmitate-stimulated BAECs and BAECs overexpressing ACSL1.
Finally, overexpression of ACSL1 did not significantly alter oxygen consumption, suggesting that the metabolic state of the ECs was not markedly different depending on ACSL1 levels ( Figure 2K ).
Endothelial ACSL1-Deficiency Does not Provide Protection From Saturated Fatty Acid-Induced Proapoptotic or Proinflammatory Changes
To investigate whether intrinsic ACSL1 promotes proapoptotic and proinflammatory changes in saturated fatty acidexposed ECs, we next generated mice with endothelium and hematopoietic-targeted ACSL1 deficiency. Acsl1 flox/flox Tie2-Cre Tg (ACSL1 E/H-/-) mice and control littermate WT controls (Acsl1 wt/wt Tie2-Cre Tg ) were genotyped ( Figure 3A ) and used for experiments. Relative Acsl1 mRNA levels were lower in heart MMECs than in heart tissue ( Figure II in the online-only Data Supplement). Acsl1 mRNA levels were reduced by 60% to 75% in freshly isolated and early passage heart MMECs from ACSL1
E/H-/-mice compared with littermate controls ( Figure 3B ), whereas mRNA levels of other ACSL isoforms were unchanged ( Figure 3B ). Furthermore, there was no detectable reduction of Acsl1 mRNA levels in livers from ACSL1
E/H-/-mice, demonstrating selective loss of ACSL1 ( Figure 3B ).
ACSL1 protein was also reduced in MMECs from ACSL1
E/H-/-mice ( Figure 3C ).
As a second approach, ACSL1 expression was knocked down by small interfering RNA (siRNA). Acsl1 siRNA reduced Acsl1 mRNA levels by 80% to 90% in MMECs, under both basal and fatty acid-stimulated conditions ( Figure 3D ). ACSL1 protein levels were also reduced, whereas no significant compensatory upregulation was found for ACSL3 or ACSL4 protein ( Figure  3E ). However, fatty acid stimulation, and especially stearate, upregulated Acsl3 and Acsl4 mRNA levels in MMECs ( Figure  3F ), suggesting that these ACSL isoforms might take on a more important role in saturated fatty acid-stimulated MMECs. No compensatory upregulation of Acsl3, Acsl4, or Acsl5 was observed in MMECs treated with Acsl1 siRNA, under basal or fatty acid-stimulated conditions ( Figure 3F ).
We next investigated fatty acid and glucose utilization in MMECs deficient in ACSL1. ACSL1 knockdown did not result in a measurable reduction in palmitate β-oxidation ( Figure IIIA in the online-only Data Supplement), no differences in glucose consumption, and a slight increase in lactate production (Figures IIIB and IIIC in the online-only Data Supplement). These experiments also demonstrated that these MMECs are highly glycolytic cells.
Cultured MMECs from WT and ACSL1 E/H-/-mice responded to saturated fatty acid stimulation with an increased secretion of CCL2 (data not shown), and increased shedding of sVCAM-1 and sICAM-1 ( Figure 4A and 4B). ACSL1 deficiency did not protect against these effects, but rather tended to exacerbate the stearate-induced effects. Furthermore, palmitate-and stearate-induced ER stress, as measured by increased Hspa5 (Grp78) and Ddit3 (Chop) mRNA levels and Xbp1 splicing ( Figure 4C and 4D and Figure IV in the online-only Data Supplement). ACSL1 deficiency did not protect the cells from the stearate-or palmitate-induced ER stress response, but rather increased levels of the chaperone Hspa5 ( Figure  4C ). ACSL1 deficiency also did not protect against saturated fatty acid-induced apoptosis, measured as DNA fragmentation ( Figure 4E ). The lack of effects of ACSL1 deficiency was confirmed in MMECs in which ACSL1 had been downregulated sICAM-1; D) shedding were analyzed by ELISAs. Caspase 3 activity was measured by a fluorometric assay in heart MMECs stimulated with 156 μmol/L 16:0 or 18:0 bound to BSA at a 1:2 molar ratio for 24 hours (E). Apoptosis was measured as DNA fragmentation (TUNEL) using the HT TiterTACS assay kit (F). n=3 to 6; mean±SEM.
by siRNA. Consistent with the results on MMECs from ACSL1 E/H-/-mice, Acsl1 siRNA did not result in an inhibition of stearate-induced sVCAM-1 or sICAM-1 shedding, ER stress response genes, or apoptosis, but rather an increase in these responses was observed ( Figure 4F-4J) . Thus, ACSL1 is not required for saturated fatty acid-induced proinflammatory and proapoptotic effects in cultured MMECs. Saturated fatty acids have been shown to mediate inflammatory effects through TLR4 in ECs, 5 and we therefore repeated some of these experiments in MMECs isolated from hearts of Tlr4 +/+ and Tlr4 -/-mice. In agreement with previous findings, TLR4 deficiency exerted a protective effect on stearate-induced CCL2 secretion, and sVCAM-1 and sICAM-1 shedding ( Figure 5A-5C ), whereas it did not significantly protect against saturated fatty acid-induced apoptosis ( Figure 5D ). Thus, in contrast to ACSL1 deficiency, TLR4 deficiency blunts the inflammatory effects of stearate. The effects of palmitate were weaker than those of stearate and were not affected by TLR4 deficiency. It is possible that palmitate mediates its effects, in part, through other mechanisms, such as through activation of TLR2.
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Endothelial ACSL1 Deficiency Does Not Confer a Protective Effect in a Mouse Model of Insulin Resistance and Dietary Fatty Acid Saturation
Exposure of cells in vitro to single fatty acids bound to BSA can be regarded as a rather simple and artificial system, 31 and we therefore next assessed the potential effects of endothelial ACSL1 deficiency in vivo. We investigated effects of endothelial ACSL1 deficiency in a mouse model of insulin resistance and obesity, in which mice are fed a diet with increased fatty acid saturation, sucrose, and cholesterol. 20, 21 Male WT and ACSL1
E/H-/-mice were fed this DDC or chow for 20 weeks. At the end of the study, DDC-fed mice were significantly obese, showed increased fasting blood glucose levels, glucose intolerance, and increased plasma cholesterol levels, as compared with chow-fed mice ( Figure 6A-6D) . Endothelial ACSL1 deficiency had no effect in chow-fed or DDC-fed mice on these parameters. Plasma levels of sICAM-1 and sVCAM-1 were not elevated by the DDC, and were not affected by ACSL1 deficiency ( Figure 6E and 6F ), but aortic levels of Vcam1 mRNA were significantly elevated by DDC-feeding ( Figure  6G ). Endothelial ACSL1 deficiency did not protect the aorta from DDC-induced Vcam1 induction ( Figure 6G ).
Macrophages are known to accumulate in adipose tissue in mice fed high-fat diets, including the diet used in the present study. 20, 21 This macrophage accumulation requires monocytes to bind to and traverse microvessels. We therefore next investigated the effect of DDC and endothelial ACSL1 deficiency in epididymal fat from chow-fed and DDC-fed mice. ACSL1
E/H-/-mice exhibited no significant differences in the number or morphology of microvessels in epididymal fat ( Figure 6H ). As expected, DDC-fed mice had significantly more macrophages in epididymal fat (measured as increased levels of the myeloid cell/macrophage markers Emr1 and Cd11b) and increased levels of Ccl2 mRNA ( Figure 6I-6K) , as compared with chow-fed mice. Endothelial ACSL1 deficiency had no effect on these parameters ( Figure 6I-6K) . Also, there were no differences in ER stress markers between the 4 groups of mice (data not shown).
To evaluate whether the mice had been exposed to elevated saturated fatty acid ratios, fatty acid composition of the chow diet and DDC as well as plasma fatty acid composition in the 4 groups of mice were analyzed by gas chromatographymass spectrometry. The DDC had higher relative levels of 16:1, 16:0, 18:1, and 18:0, and lower relative levels of 18:2 as compared with the chow diet, and the ratio of saturated fatty acids/unsaturated fatty acids was significantly higher ( Figure 6L ). Plasma levels of fatty acids in the 4 groups of mice generally reflected the fatty acid composition of the diet. Thus, mice fed DDC exhibited lower relative levels of 18:2 and higher relative levels of 18:1 and 18:0, as compared with chow-fed mice ( Figure 6M ). There were no differences in 16:0 plasma levels between the different groups. Endothelial ACSL1 deficiency did not alter plasma fatty acid composition ( Figure 6M ). Finally, cultured MMECs were exposed to fatty acid ratios mimicking those found in plasma of chow-fed and DDC-fed mice. The fatty acids were bound to BSA at a 1:2 BSA:fatty acid ratio. As shown at Figure 6N , sVCAM-1 shedding was the same in MMECs exposed to fatty acid ratios mimicking plasma fatty acid ratios in chowfed mice and DDC-fed mice. Similarly, CCL2 secretion, sICAM-1 shedding, and apoptosis were the same in both groups (data not shown).
These studies suggest that endothelial ACSL1 deficiency does not protect mice from a diet rich in saturated fatty acids on adipose tissue macrophage accumulation or aortic VCAM-1 expression, consistent with the in vitro studies. 
Discussion
We demonstrate that, whereas forced overexpression of ACSL1 in ECs results in exacerbation of apoptosis, ER stress, and JNK activation induced by saturated fatty acids, ACSL1 deficiency does not protect ECs in vitro or in vivo from the detrimental effects of a saturated fatty acid-rich environment. Thus, overexpression of ACSL1 is likely to cause effects that are not normally conferred by ACSL1, perhaps because downstream enzymes that further process the generated palmitoyl-CoA and stearoyl-CoA are not able to efficiently deal with the increased acyl-CoA levels. In addition, overexpression of ACSL1 is likely to result in increased uptake and trapping of saturated fatty acids through vectorial acylation, especially under in vitro conditions in which only saturated fatty acids are provided. Consistent with these findings, overexpression of ACSL1 in the heart causes increased apoptosis and cardiomyopathy, 17 and this can be prevented by also overexpressing diacylglycerol acyltransferase 1, which promotes downstream triacylglycerol formation. 32 Palmitate has previously been shown to cause ER stress and apoptosis by increasing ER membrane saturation. 12 Our finding that ACSL1 overexpression exacerbates palmitate-induced apoptosis, ER stress, and membrane palmitate accumulation suggests that ACSL1 has the ability to enhance this pathway in ECs.
ACSL1 normally expressed in ECs is likely to act in different subcellular compartments or on different fatty acids, as compared with overexpressed ACSL1 because endothelial ACSL1 deficiency did not protect ECs from saturated fatty acid-induced apoptosis, ER stress, or release of inflammatory mediators, nor did ACSL1
E/H-/-mice show a clear phenotype in a mouse model of insulin resistance associated with saturated fatty acid feeding. Instead, other ACSL isoforms or other enzymes with acyl-CoA synthetase activity are likely to mediate at least part of the effects of saturated fatty acids in ECs. This conclusion is based on the lack of effect of ACSL1 deficiency on saturated fatty acid-mediated effects, and also on the finding that triacsin C, a pharmacological general ACSL inhibitor, prevents saturated fatty acid-induced apoptosis, 13, 26 indicating that a triacsin C-inhibitable enzyme(s) is, in part, responsible for the saturated fatty acid effects in E/H-/-mice were fed regular chow or diabetogenic diet with added cholesterol (DDC) for 20 weeks. A, Body weights at the end of the study. B, Fasting (5 hours) blood glucose levels at week 18. C, Glucose tolerance tests were performed at week 18 by injecting 1.5 g/kg dextrose into 5-hour fasted mice, and blood glucose was measured at indicated times. D, Plasma cholesterol levels at the end of the study. E and F, Plasma soluble intracellular adhesion molecule 1 (sICAM-1) and soluble vascular cell adhesion molecule 1 (sVCAM-1) levels at the end of the study. G, Aortae were harvested in RNA-later (Qiagen, Valencia, CA), and levels of Vcam1 mRNA were measured by real-time PCR. H, Epididymal fat pads were isolated and sectioned. An anti-von Willebrand factor antibody was used to detect endothelial cells (ECs) in microvessels. Scale bar, 20 μm. I-K, The macrophage markers Emr1 (F4/80) and Cd11b, and Ccl2 mRNA were measured in epididymal adipose tissue by real-time PCR. L, Fatty acid composition of the chow diet and DDC was analyzed by gas chromatography-mass spectrometry (GC-MS) and was expressed as saturated/unsaturated fatty acid ratio. M, Fatty acid composition of plasma samples was measured by GC-MS. N, sVCAM-1 shedding was measured by ELISA from mouse microvascular endothelial cells (MMECs) incubated in the presence of fatty acid ratios reflecting plasma fatty acids in chow-fed and DDC-fed mice. n=5 to 8 per group; mean±SEM; white bars indicate WT mice; and gray bars, ACSL1
E/H-/-mice (A-G, I-K, M). In L and N, white bars indicate chow diet (L) or a fatty acid ratio mimicking that of chow diet (N) whereas gray bars indicate DDC (L) or a fatty acid ratio mimicking that of DDC (N).
ECs, consistent with results from the present study, which demonstrated that triacsin C prevents the proinflammatory and proapoptotic effects of palmitate in BAECs. ACSL1 acts on a broad range of fatty acids, but is not specific to saturated fatty acids. For example, in hepatocytes, oleoyl-CoA levels are most reduced by ACSL1 deficiency, 19 whereas in thioglycollate-elicited macrophages, arachidonoyl-CoA levels are preferentially reduced by ACSL1 deficiency. 18 As ECs do not express significant levels of ACSL6, it is possible that the effects of palmitate and stearate are mediated by ACSL4, ACSL3, and ACSL5 in ECs. Consistently, our results suggest an increase in ACSL3 and ACSL4 expression in fatty acidstimulated ECs. However, part of the effect of saturated fatty acids on release of inflammatory markers and apoptosis might be mediated by the free fatty acids, for example, by altering membrane biophysical properties. The tendency of ACSL1 deficiency to exacerbate the effects of stearate supports this interpretation. Contrary to ACSL1 deficiency, TLR4 deficiency conferred protective effects against the inflammatory effects of stearate, consistent with published studies. 5 Thus, ACSL1 deficiency and TLR4 deficiency exert the opposite effects in stearate-stimulated ECs.
Rather than mediating effects of saturated fatty acids, ACSL1 appears to have other biological functions in ECs. ACSL1 has a prominent role in mediating β-oxidation in many tissues depending on fatty acids as an energy source, such as heart, liver, and adipose tissue. 19, 33, 34 Conversely, we have recently demonstrated that in macrophages, ACSL1 does not contribute to β-oxidation, but has a prominent role in mediating inflammatory changes in response to diabetes mellitus, most likely by acting on arachidonic acid. 18 ACSL1 also does not appear to contribute to β-oxidation in ECs, at least not under the conditions tested. Overall, these studies support the hypothesis that ACSL isoforms may have distinct biological functions that are context-and cell type-dependent, and perhaps dependent on the availability of different fatty acid substrates under different conditions, as well as the metabolism of the cell. The current work is the first study to investigate the biological role of any of the ACSL isoforms in ECs in vivo. Future studies on endothelial ACSL1 include its potential role in atherosclerosis, vasoreactivity, and blood pressure regulation, as well as evaluation of potential effects of ACSL1 on endothelial nitric oxide synthase activity. The study also raises more complex questions. For example, to what extent do plasma levels of saturated fatty acids contribute to inflammatory reactions in vivo? Ratios of fatty acids mimicking those found in plasma of mice fed the high-fat diet used in the present study did not promote inflammatory changes or apoptosis, as compared with ratios of fatty acids reflecting plasma levels in chow-fed mice. It is possible that the inflammatory effects of diets rich in saturated fatty acids are due to associated systemic factors, such as cholesterol, 20 or to increased tissue levels of saturated fatty acids or acyl-CoAs. In this context, it is interesting to speculate that upregulation of ACSL1 or other ACSL isoforms under inflammatory conditions 18 might lead to increased trapping of fatty acids as acylCoAs in tissues, regardless of plasma fatty acid levels.
In conclusion, this study shows that although overexpressed ACSL1 can act to exacerbate detrimental effects of saturated fatty acids in ECs, normally, ACSL1 does not mediate the inflammatory or apoptotic effects of a saturated fatty acid-rich environment.
